.

Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Accenture
Boehringer Ingelheim
Dow
Chubb
US Department of Justice
Teva
AstraZeneca
Federal Trade Commission
Mallinckrodt

Generated: June 28, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: dalbavancin hydrochloride

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Durata Theraps Intl
DALVANCE
dalbavancin hydrochloride
POWDER;IV (INFUSION)021883NDADurata Therapeutics Inc.57970-100-011 VIAL in 1 PACKAGE (57970-100-01) > 25 mL in 1 VIAL
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
Teva
US Department of Justice
Cantor Fitzgerald
QuintilesIMS
Healthtrust
Johnson and Johnson
McKesson
Medtronic
Farmers Insurance

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot